These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31258835)

  • 1. Dissecting the expression landscape of cytochromes P450 in hepatocellular carcinoma: towards novel molecular biomarkers.
    Brodeur CM; Thibault P; Durand M; Perreault JP; Bisaillon M
    Genes Cancer; 2019 May; 10(3-4):97-108. PubMed ID: 31258835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.
    Yin F; Shu L; Liu X; Li T; Peng T; Nan Y; Li S; Zeng X; Qiu X
    J Exp Clin Cancer Res; 2016 Aug; 35(1):127. PubMed ID: 27567667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma.
    Tremblay MP; Armero VE; Allaire A; Boudreault S; Martenon-Brodeur C; Durand M; Lapointe E; Thibault P; Tremblay-Létourneau M; Perreault JP; Scott MS; Bisaillon M
    BMC Genomics; 2016 Aug; 17(1):683. PubMed ID: 27565572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hedgehog signaling as a potential oncogenic driver in an aggressive subclass of human hepatocellular carcinoma: A reanalysis of the TCGA cohort.
    Zhao Y; Zhang L; Zhang Y; Meng B; Ying W; Qian X
    Sci China Life Sci; 2019 Nov; 62(11):1481-1491. PubMed ID: 31313086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of crucial genes based on expression profiles of hepatocellular carcinomas by bioinformatics analysis.
    Liu ZK; Zhang RY; Yong YL; Zhang ZY; Li C; Chen ZN; Bian H
    PeerJ; 2019; 7():e7436. PubMed ID: 31410310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
    Likhitrattanapisal S; Tipanee J; Janvilisri T
    Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs.
    Selitsky SR; Dinh TA; Toth CL; Kurtz CL; Honda M; Struck BR; Kaneko S; Vickers KC; Lemon SM; Sethupathy P
    mBio; 2015 Dec; 6(6):e01500-15. PubMed ID: 26646011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties.
    Cai J; Li B; Zhu Y; Fang X; Zhu M; Wang M; Liu S; Jiang X; Zheng J; Zhang X; Chen P
    EBioMedicine; 2017 May; 19():18-30. PubMed ID: 28434945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
    Matsushita J; Suzuki T; Okamura K; Ichihara G; Nohara K
    Environ Health Prev Med; 2020 Jul; 25(1):31. PubMed ID: 32703154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Plasma hsa-miR122 in HBV-Related Hepatocellular Carcinoma (HCC) in Vietnamese Patients.
    Quoc NB; Phuong NDN; Ngan TK; Linh NTM; Cuong PH; Chau NNB
    Microrna; 2018; 7(2):92-99. PubMed ID: 29701140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 12. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.
    Chiou SH; Lee KT
    Kaohsiung J Med Sci; 2016 Nov; 32(11):535-544. PubMed ID: 27847095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis.
    Xia Q; Li Z; Zheng J; Zhang X; Di Y; Ding J; Yu D; Yan L; Shen L; Yan D; Jia N; Chen W; Feng Y; Wang J
    J Cell Physiol; 2019 Apr; 234(4):4851-4863. PubMed ID: 30272824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma.
    Zheng H; Li P; Kwok JG; Korrapati A; Li WT; Qu Y; Wang XQ; Kisseleva T; Wang-Rodriguez J; Ongkeko WM
    Oncotarget; 2018 Jan; 9(1):224-235. PubMed ID: 29416609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus.
    Zekri AR; Hassan ZK; Bahnassy AA; Sherif GM; ELdahshan D; Abouelhoda M; Ali A; Hafez MM
    Asian Pac J Cancer Prev; 2012; 13(11):5433-8. PubMed ID: 23317196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Pathways Enhancement Confers Poor Prognosis in p53 Exon Mutant Hepatocellular Carcinoma.
    Chen PM; Li JR; Liu CC; Tang FY; Chiang EI
    Cancer Inform; 2020; 19():1176935119899913. PubMed ID: 31933519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
    Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
    Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma.
    Chen Q; Li F; Gao Y; Xu G; Liang L; Xu J
    Front Oncol; 2020; 10():1210. PubMed ID: 32903581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of prognostic biomarkers for patients with hepatocellular carcinoma after hepatectomy.
    Wang X; Liao X; Yang C; Huang K; Yu T; Yu L; Han C; Zhu G; Zeng X; Liu Z; Zhou X; Qin W; Su H; Ye X; Peng T
    Oncol Rep; 2019 Mar; 41(3):1586-1602. PubMed ID: 30628708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
    Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.